Table 4.
Practice pattern and recurrence rate according to tumor and patient characteristics
| Combined modalities recurrence rate |
Single modality recurrence rate |
||||
|---|---|---|---|---|---|
| % | Number | % | Number | P | |
| Age, years | |||||
| <69 | 29 | (6/21) | 75 | (3/4) | 0.076 |
| ≥70 | 23 | (3/13) | 36 | (4/11) | 0.476 |
| Histological type | |||||
| SCC | 21 | (6/30) | 42 | (5/12) | 0.149 |
| Others | 75 | (3/-4) | 67 | (2/3) | 0.809 |
| FIGO stage | |||||
| I/II | 15 | (4/26) | 46 | (6/13) | 0.038 |
| III/IV | 50 | (4/8) | 100 | (2/2) | 0.197 |
| Clinical N stage | |||||
| N0 | 18 | (4/22) | 42 | (5/12) | 0.137 |
| N1 | 33 | (4/12) | 100 | (3/3) | 0.038 |
| Size, cm | |||||
| <4 | 17 | (4/23) | 43 | (3/8) | 0.241 |
| ≥4 | 45 | (5/11) | 57 | (4/7) | 0.629 |
| Involvement of lower 1/3 | |||||
| No | 19 | (4/21) | 44 | (4/9) | 0.149 |
| Yes | 38 | (5/13) | 50 | (3/6) | 0.636 |
SCC = squamous cell carcinonma, FIGO = International Federation of Gynecology and Obstetrics.